Marimed (MRMD) Total Non-Current Liabilities (2011 - 2025)

Marimed (MRMD) has 15 years of Total Non-Current Liabilities data on file, last reported at $137.8 million in Q4 2025.

• On a quarterly basis, Total Non-Current Liabilities rose 6.56% year-over-year to $137.8 million in Q4 2025; TTM through Dec 2025 was $137.8 million, a 6.56% increase from a year earlier, with the FY2025 full-year figure at $137.8 million, up 6.56% from the prior year.
• Total Non-Current Liabilities for Q4 2025 stood at $137.8 million, up from $136.5 million in the prior quarter.
• Over the last five years, Total Non-Current Liabilities for MRMD reached as high as $137.8 million in Q4 2025 and fell as low as $37.5 million in Q1 2021.
• Historically, Total Non-Current Liabilities has averaged $89.3 million across 5 years, with a median of $89.2 million in 2023.
• Across the five-year window, Total Non-Current Liabilities plunged 36.32% in 2021 and surged 87.69% in 2023, its largest moves.
• Year by year, Total Non-Current Liabilities stood at $49.1 million in 2021, then climbed by 16.27% to $57.1 million in 2022, then jumped by 87.69% to $107.1 million in 2023, then advanced by 20.76% to $129.3 million in 2024, then climbed by 6.56% to $137.8 million in 2025.
• Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $137.8 million in Q4 2025, $136.5 million in Q3 2025, and $131.1 million in Q2 2025.